enow.com Web Search

  1. Ads

    related to: alk mutation lung cancer treatment

Search results

  1. Results from the WOW.Com Content Network
  2. ALK positive lung cancer - Wikipedia

    en.wikipedia.org/wiki/ALK_positive_lung_cancer

    ALK positive lung cancer is a primary malignant lung tumor whose cells contain a characteristic abnormal configuration of DNA wherein, most frequently, the echinoderm microtubule-associated protein-like 4 gene is fused to the anaplastic lymphoma kinase (ALK) gene.

  3. ALK inhibitor - Wikipedia

    en.wikipedia.org/wiki/ALK_inhibitor

    ALK inhibitors are anti-cancer drugs that act on tumours with variations of anaplastic lymphoma kinase (ALK) such as an EML4-ALK translocation. [1] They fall under the category of tyrosine kinase inhibitors , which work by inhibiting proteins involved in the abnormal growth of tumour cells.

  4. Crizotinib - Wikipedia

    en.wikipedia.org/wiki/Crizotinib

    Crizotinib is indicated for the treatment of metastatic non-small cell lung cancer (NSCLC) or relapsed or refractory, systemic anaplastic large cell lymphoma (ALCL) that is ALK-positive. [ 2 ] [ 3 ] It is also indicated for the treatment of unresectable, recurrent, or refractory inflammatory anaplastic lymphoma kinase (ALK)-positive ...

  5. Anaplastic lymphoma kinase - Wikipedia

    en.wikipedia.org/wiki/Anaplastic_lymphoma_kinase

    Xalkori , produced by Pfizer, was approved by the FDA for treatment of late stage lung cancer on August 26, 2011. [76] Early results of an initial Phase I trial with 82 patients with ALK induced lung cancer showed an overall response rate of 57%, a disease control rate at 8 weeks of 87% and progression free survival at 6 months of 72%.

  6. Brigatinib - Wikipedia

    en.wikipedia.org/wiki/Brigatinib

    Brigatinib is an inhibitor of ALK [3] and mutated EGFR. [5]ALK was first identified as a chromosomal rearrangement in anaplastic large cell lymphoma (ALCL). Genetic studies indicate that abnormal expression of ALK is a key driver of certain types of non-small cell lung cancer (NSCLC) and neuroblastomas, as well as ALCL.

  7. Targeted therapy of lung cancer - Wikipedia

    en.wikipedia.org/.../Targeted_therapy_of_lung_cancer

    About 2% of all lung cancers are non-carcinoma (mainly sarcoma, tumors of hematopoietic origin, or germ cell tumors. [5] These forms of lung cancer are usually treated differently from carcinomas. Because of the ubiquity of lung carcinomas, however, the term "lung cancer" generally refers to carcinomas in everyday clinical practice. [citation ...

  1. Ads

    related to: alk mutation lung cancer treatment